Potentially Cancer-Causing Contaminant Found In Januvia: FDA
Some batches of Januvia, a diabetes drug, contain high levels of nitrosamines which could increase cancer risks, the FDA warns.
Tag Archives: Januvia
-
-
Diabetes Drug Lawsuits Over Pancreatic Cancer Risk Dismissed, Again
A federal judge has again dismissed hundreds of diabetes drug lawsuits alleging medications like Byetta and Januvia can cause pancreatic cancer.
-
Januvia Pancreatic Cancer Lawsuit To Be Decided By Jury, Illinois Appeals Court Determines
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.
-
Basal Insulin, Sulfonylureas Linked With Increased Heart Risks: Study
A new study warns that older diabetes drugs may increase the risk of heart problems, and suggests doctors use newer medications as second-line treatments.
-
Amputation Risk with Invokana, Similar Diabetes Drugs Highlighted in New Study
Another study appears to link Invokana and similar diabetes drugs with an increased risk of leg and foot amputations.
-
Byetta, Victoza and Januvia Lawsuits Over Pancreatic Cancer Mount in Reinstated Litigation
A growing number of lawsuits over claims that Byetta, Victoza and similar diabetes drugs can cause pancreatic cancer are being filed in the wake of a recent decision to reinstate…
-
Pancreatic Cancer Lawsuits Over Januvia, Byetta and Victoza Not Set For Bellwether Trials Until 2020
A new schedule for Byetta, Januvia and Victoza pancreatic cancer lawsuits sets the first bellwether trial for January 2020.
-
Hundreds of Januvia, Victoza, Byetta Lawsuits Reinstated by Appeals Court Ruling
More than 700 Victoza, Byetta, Januvia and Janumet pancreatic cancer lawsuits have been reinstated by a federal appeals court, overturning a summary judgment that led to their dismissal in 2015.
-
Side Effects of Invokana, Similar Drugs, Double Risk of Diabetic Ketoacidosis: Study
A new study highlights the diabetic ketoacidosis risk with Invokana, indicating that users of the new generation diabetes drug may be twice as likely to develop this dangerous build up…
-
Study Finds Little Difference Between Diabetes Drugs’ Effectiveness
The findings of a new study suggest that there is little difference between a variety of diabetes drugs currently on the market, despite a wide range of risks.